Our broad portfolio consists of multiplex panels that allow you to choose, within the panel, analytes that best meet your needs. On a separate tab you can choose the premixed cytokine format or a single plex kit.
Cell Signaling Kits & MAPmates™
Choose fixed kits that allow you to explore entire pathways or processes. Or design your own kits by choosing single plex MAPmates™, following the provided guidelines.
The following MAPmates™ should not be plexed together:
-MAPmates™ that require a different assay buffer
-Phospho-specific and total MAPmate™ pairs, e.g. total GSK3β and GSK3β (Ser 9)
-PanTyr and site-specific MAPmates™, e.g. Phospho-EGF Receptor and phospho-STAT1 (Tyr701)
-More than 1 phospho-MAPmate™ for a single target (Akt, STAT3)
-GAPDH and β-Tubulin cannot be plexed with kits or MAPmates™ containing panTyr
.
Catalogue Number
Ordering Description
Qty/Pack
List
This item has been added to favorites.
Select A Species, Panel Type, Kit or Sample Type
To begin designing your MILLIPLEX® MAP kit select a species, a panel type or kit of interest.
Custom Premix Selecting "Custom Premix" option means that all of the beads you have chosen will be premixed in manufacturing before the kit is sent to you.
Catalogue Number
Ordering Description
Qty/Pack
List
This item has been added to favorites.
Species
Panel Type
Selected Kit
Qty
Catalogue Number
Ordering Description
Qty/Pack
List Price
96-Well Plate
Qty
Catalogue Number
Ordering Description
Qty/Pack
List Price
Add Additional Reagents (Buffer and Detection Kit is required for use with MAPmates)
Qty
Catalogue Number
Ordering Description
Qty/Pack
List Price
48-602MAG
Buffer Detection Kit for Magnetic Beads
1 Kit
Space Saver Option Customers purchasing multiple kits may choose to save storage space by eliminating the kit packaging and receiving their multiplex assay components in plastic bags for more compact storage.
This item has been added to favorites.
The Product Has Been Added To Your Cart
You can now customize another kit, choose a premixed kit, check out or close the ordering tool.
Dissolution testing is required by regulatory agencies before a drug can be released for clinical use or on the market. These tests are used in the development and evaluation of new formulations, for quality control of the drug product and to ensure that changes in the manufacturing process have no effect on the drug product quality and performance. Dissolution testing is also a useful tool to establish in vitro / in vivo correlations (IVIVC).
Many drugs are formulated as solid dosage forms for oral administration. Dissolution testing is used to predict the absorption of these drugs. It allows the study of the release of the active ingredient from the excipients of the dosage form (usually a tablet or a capsule) as well as its dissolution under physiological conditions. The dissolution medium is usually a buffer solution of either pH 1.2 (to represent gastric fluid), or 6.8 (to represent intestinal fluid), but other dissolution media may be used depending on the physicochemical characteristics of the drug and on the properties of its formulation. For example, surfactants or enzymes may be added to the buffers. The dissolution medium is placed in a vessel, and maintained at constant temperature (usually 37±0.5°C). Mild agitation conditions are maintained throughout the test. The most commonly used methods are the basket (Apparatus 1) and the paddle (Apparatus 2), but many other methods are available (flow-through, etc.). Samples are collected at specific times and analyzed.
Performing dissolution testing for more complex dosage forms such as extended-release formulations, transdermal patches, etc. presents a challenge, and specific dissolution testing procedures are being developed for them. Dissolution testing methods are established by local Pharmacopeias. The Pharmacopoeial Discussion Group (PDG) aims at harmonizing the methods described by the United States Pharmacopeia (USP), the European Pharmacopeia and the Japanese Pharmacopeia